Renalytix Ai Stock Analysis
RNLX Stock | USD 0.63 0.01 1.61% |
Renalytix AI is undervalued with Real Value of 1.64 and Target Price of 4.67. The main objective of Renalytix stock analysis is to determine its intrinsic value, which is an estimate of what Renalytix AI is worth, separate from its market price. There are two main types of Renalytix's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Renalytix's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Renalytix's stock to identify patterns and trends that may indicate its future price movements.
The Renalytix stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Renalytix is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Renalytix Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Renalytix's ongoing operational relationships across important fundamental and technical indicators.
Renalytix |
Renalytix Stock Analysis Notes
The company recorded a loss per share of 0.9. Renalytix AI had not issued any dividends in recent years. Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. Renalytix Plc was incorporated in 2018 and is headquartered in New York, New York. Renalytix operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 51 people. To find out more about Renalytix AI contact the company at 646 397 3970 or learn more at https://renalytix.com.Renalytix AI Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Renalytix's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Renalytix AI or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Renalytix AI is way too risky over 90 days horizon | |
Renalytix AI has some characteristics of a very speculative penny stock | |
Renalytix AI appears to be risky and price may revert if volatility continues | |
Renalytix AI has high likelihood to experience some financial distress in the next 2 years | |
The company reported the previous year's revenue of 3.4 M. Net Loss for the year was (46.22 M) with profit before overhead, payroll, taxes, and interest of 720 K. | |
Renalytix AI currently holds about 32.36 M in cash with (32.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.89, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
Renalytix AI has a poor financial position based on the latest SEC disclosures | |
Latest headline from MacroaxisInsider: Acquisition by Icahn School Of Medicine At Mount Sinai of 9360374 shares of Renalytix at 0.25 subject to Rule 16b-3 |
Renalytix AI Upcoming and Recent Events
Earnings reports are used by Renalytix to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Renalytix previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
4th of April 2024 Upcoming Quarterly Report | View | |
14th of June 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
26th of September 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
30th of June 2023 Last Financial Announcement | View |
Renalytix Largest EPS Surprises
Earnings surprises can significantly impact Renalytix's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2021-12-07 | 2021-09-30 | -0.12 | -0.14 | -0.02 | 16 | ||
2024-02-15 | 2023-12-31 | -0.09 | -0.18 | -0.09 | 100 | ||
2021-06-15 | 2021-03-31 | -0.145 | -0.24 | -0.095 | 65 |
Renalytix Thematic Classifications
In addition to having Renalytix stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Data StorageData Storage |
Renalytix Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Renalytix is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Renalytix AI backward and forwards among themselves. Renalytix's institutional investor refers to the entity that pools money to purchase Renalytix's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Ewa, Llc | 2023-12-31 | 34.5 K | North Star Investment Management Corp | 2023-12-31 | 31 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 29.7 K | Xtx Topco Ltd | 2023-12-31 | 22 K | Wealth Enhancement Advisory Services, Llc | 2023-12-31 | 19.6 K | Lpl Financial Corp | 2023-12-31 | 18.5 K | Virtu Financial Llc | 2023-12-31 | 14.7 K | Ironwood Investment Counsel, Llc | 2023-12-31 | 12 K | Envestnet Asset Management Inc | 2023-09-30 | 10.9 K | Cvi Holdings Llc | 2023-12-31 | 1.1 M | Gilder Gagnon Howe & Co Llc | 2023-12-31 | 879.5 K |
Renalytix Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 40.1 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Renalytix's market, we take the total number of its shares issued and multiply it by Renalytix's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Renalytix Profitablity
Renalytix's profitability indicators refer to fundamental financial ratios that showcase Renalytix's ability to generate income relative to its revenue or operating costs. If, let's say, Renalytix is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Renalytix's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Renalytix's profitability requires more research than a typical breakdown of Renalytix's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (1.80) | (1.71) | |
Return On Capital Employed | (1.87) | (1.78) | |
Return On Assets | (1.26) | (1.20) | |
Return On Equity | (2.88) | (2.74) |
Management Efficiency
Renalytix AI has return on total asset (ROA) of (0.8832) % which means that it has lost $0.8832 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (6.514) %, meaning that it created substantial loss on money invested by shareholders. Renalytix's management efficiency ratios could be used to measure how well Renalytix manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -1.71 in 2024. Return On Capital Employed is likely to rise to -1.78 in 2024. At this time, Renalytix's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 18 M in 2024, whereas Net Tangible Assets are likely to drop slightly above 7.6 M in 2024.Last Reported | Projected for Next Year | ||
Book Value Per Share | 0.52 | 0.49 | |
Net Current Asset Value | 0.00 | 0.00 | |
Tangible Asset Value | 0.00 | 0.00 | |
Tangible Book Value Per Share | 0.40 | 0.72 | |
Enterprise Value Over EBITDA | (2.73) | (2.86) | |
Price Book Value Ratio | 7.48 | 9.12 | |
Enterprise Value Multiple | (2.73) | (2.86) | |
Price Fair Value | 7.48 | 9.12 | |
Enterprise Value | 69.7 M | 66.2 M |
The analysis of Renalytix's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Renalytix's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Renalytix Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 1.91 |
Technical Drivers
As of the 27th of April, Renalytix holds the Semi Deviation of 9.1, risk adjusted performance of 0.0822, and Coefficient Of Variation of 862.41. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Renalytix, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to break down and interpolate nineteen technical drivers for Renalytix AI, which can be compared to its competitors. Please check Renalytix AI variance and potential upside to decide if Renalytix AI is priced some-what accurately, providing market reflects its current price of 0.63 per share. As Renalytix AI is a penny stock we also suggest to check out its total risk alpha numbers.Renalytix AI Price Movement Analysis
null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Renalytix middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Renalytix AI. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Renalytix AI Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Renalytix insiders, such as employees or executives, is commonly permitted as long as it does not rely on Renalytix's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Renalytix insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Icahn School Of Medicine At Mount Sinai 3 days ago Acquisition by Icahn School Of Medicine At Mount Sinai of 9360374 shares of Renalytix at 0.25 subject to Rule 16b-3 | ||
Coste Catherine over three months ago Acquisition by Coste Catherine of 95000 shares of Renalytix subject to Rule 16b-3 | ||
Mclain Thomas H over six months ago Acquisition by Mclain Thomas H of 200000 shares of Renalytix subject to Rule 16b-3 |
Renalytix Predictive Daily Indicators
Renalytix intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Renalytix stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Renalytix Forecast Models
Renalytix's time-series forecasting models are one of many Renalytix's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Renalytix's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Renalytix Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Renalytix prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Renalytix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Renalytix. By using and applying Renalytix Stock analysis, traders can create a robust methodology for identifying Renalytix entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (12.22) | (12.84) | |
Operating Profit Margin | (11.20) | (11.76) | |
Net Loss | (12.22) | (12.84) | |
Gross Profit Margin | 0.24 | 0.36 |
Current Renalytix Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Renalytix analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Renalytix analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
4.67 | Strong Buy | 1 | Odds |
Most Renalytix analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Renalytix stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Renalytix AI, talking to its executives and customers, or listening to Renalytix conference calls.
Renalytix Stock Analysis Indicators
Renalytix AI stock analysis indicators help investors evaluate how Renalytix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Renalytix shares will generate the highest return on investment. By understating and applying Renalytix stock analysis, traders can identify Renalytix position entry and exit signals to maximize returns.
Begin Period Cash Flow | 41.3 M | |
Long Term Debt | 7.5 M | |
Common Stock Shares Outstanding | 41.1 M | |
Total Stockholder Equity | 18.5 M | |
Tax Provision | 2000.00 | |
Property Plant And Equipment Net | 1.2 M | |
Cash And Short Term Investments | 26.1 M | |
Cash | 24.7 M | |
Accounts Payable | 11.5 M | |
Net Debt | -12.5 M | |
50 Day M A | 0.8828 | |
Total Current Liabilities | 16.1 M | |
Other Operating Expenses | 45.8 M | |
Non Current Assets Total | 13.8 M | |
Non Currrent Assets Other | 51 K | |
Stock Based Compensation | 2.9 M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Renalytix AI. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for Renalytix Stock analysis
When running Renalytix's price analysis, check to measure Renalytix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix is operating at the current time. Most of Renalytix's value examination focuses on studying past and present price action to predict the probability of Renalytix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renalytix's price. Additionally, you may evaluate how the addition of Renalytix to your portfolios can decrease your overall portfolio volatility.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |
Is Renalytix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Renalytix. If investors know Renalytix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Renalytix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.90) | Revenue Per Share 0.052 | Quarterly Revenue Growth (0.41) | Return On Assets (0.88) | Return On Equity (6.51) |
The market value of Renalytix AI is measured differently than its book value, which is the value of Renalytix that is recorded on the company's balance sheet. Investors also form their own opinion of Renalytix's value that differs from its market value or its book value, called intrinsic value, which is Renalytix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Renalytix's market value can be influenced by many factors that don't directly affect Renalytix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Renalytix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Renalytix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Renalytix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.